OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial

By afschroeder • March 20, 2026

Alhelaly M, Soylu C, Oncel D, Corradetti G, Chen K, Jackson NJ, Rathinam SR, Gonzales JA, Thundikandy R, Kanakath AV, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Sadda SR, Madow B, Coyne AB, Acharya NR, Tsui E. OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial. Ophthalmol Sci. 2026 Feb 5;6(4):101106. doi: 10.1016/j.xops.2026.101106. PMID: 41853570; PMCID: PMC12995472.

Tags: DOM STAT, FAST, General Internal Medicine, OCT-based vitreous signal intensity, Publications, Standardization of Uveitis nomenclature, uveitis, Vitreous haze

Assessing the Reliability of Telehealth Geriatric Screening in Older Adults Undergoing Surgery

Canales C, Ivanson HC, Brooks R, Smith J, Boulos NM, Grogan T, Singh S, Sarkisian C, Cannesson M, Whittington R. Assessing the Reliability of Telehealth[...]

Early discontinuation of chemotherapy in older adults with early breast cancer: results from the prospective multicenter HOPE study

Ji J, Sun CL, Dale W, Cohen HJ, Kim H, Katheria V, Baclig N, Zektser Y, Niknafs A, Margolis S, Lee C, Smith C, Sedrak[...]

Federal Housing Assistance, Treatment, and Survival in Older Adults With Non-Small Cell Lung Cancer

Fan Q, Hu X, Warren JL, Soulos PR, Katana Ogongo M, Blackford AL, Craig TK, Hussaini SMQ, Chen KL, Feliciano J, Gross CP, Polsky D,[...]